New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Medtronic launches quadripolar CRT leads in Europe, more product news.
You may also be interested in...
Medtronic, St. Jude Launch New Quadripolar Devices
Medtronic has launched two more Attain Performa left ventricular quadripolar leads for the Viva Quad XT and Viva Quad S cardiac resynchronization therapy defibrillators following FDA approval announced Dec. 11. On the same day, St. Jude announced CE mark of the Quadra Allure MP cardiac resynchronization therapy pacemaker, the first quadripolar CRT-P with MultiPoint pacing.
New Product Briefs: Medtronic CRT-D; Syncardia Valve; Lombard AAA Graft
Medtronic is set for the U.S. launch of the Viva Quad XT and Viva Quad S cardiac resynchronization devices. Syncardia earns FDA approval for a new propriety valve set for its total artificial heart. Lombard earns Japanese approval for its AAA graft. Philips announces a unique case in Canada.
FDA Approves St. Jude’s Quadripolar CRT-D Device Following Delay
The approval is significant as it marks the entry of the first quadripolar pacing system into the U.S. market. But St. Jude may not get as big of a positive gain from the product as previously expected, analysts suggest.